MeiraGTx Holdings PLC (MGTX) vs Rigel Pharmaceuticals, Inc. (RIGL)
- MeiraGTx Holdings PLC MGTX 9.28 −6.17%
- Rigel Pharmaceuticals, Inc. RIGL 45.97 −2.71%
MeiraGTx Holdings PLC and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. MeiraGTx Holdings PLC and Rigel Pharmaceuticals, Inc. are of similar size ($949.9M and $882.6M). Rigel Pharmaceuticals, Inc. trades at the lower P/E: 2.6× against 12.2×. MeiraGTx Holdings PLC grew revenue faster over the last twelve months: 948.4% against 3.31%. Rigel Pharmaceuticals, Inc. has the higher net margin (116.3% vs 19.9%) and the lower return on invested capital (16.5% vs 66.6%). Across the 21 metrics below, MeiraGTx Holdings PLC leads on 11 and Rigel Pharmaceuticals, Inc. on 10.
Valuation
Profitability
| Metric | MGTX | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.95% | 91.39% | 65.16% |
| Operating margin | 46.30% | 31.45% | 0.00% |
| Net margin | 19.87% | 116.30% | 0.00% |
| Free cash flow margin | 2.55% | 3.19% | 0.00% |
| Return on equity | 72.22% | 126.90% | (56.36%) |
| Return on assets | 26.54% | 88.46% | (48.04%) |
| Return on invested capital | 66.60% | 16.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack